Bionano Genomics, Inc.
Bionano Genomics, Inc. (BNGO) Stock Overview
Explore Bionano Genomics, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
3.7M
P/E Ratio
-0.16
EPS (TTM)
$-12.77
ROE
-0.86%
BNGO Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Bionano Genomics, Inc. (BNGO) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 32.56, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $0.00.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.16 and a market capitalization of 3.7M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.